Sandra Anderson

Sandra joined Innomar in 2005. With more than 20 years of pharmaceutical and clinical experience, she oversees a diverse team of 60 associates focused on regulatory, reimbursement, health economics, market access, business development, marketing, and stakeholder relations. Sandra’s taken on multiple leadership roles at Innomar, that include launching and growing the pharmacovigilance team, designing and leading the training department, leading patient support programs and building the stakeholder relations division.

Sandra has also taken leadership roles in multiple mergers and acquisitions. Sandra is a champion for the integrated model, the value of partnership and creating outstanding customer experiences. Before joining Innomar, Sandra worked for Merk Frosst Canada in their Specialty Division, focusing on the ophthalmology, urology and neurology portfolios. She started her career as a Clinical Research Associate. Sandra has deep knowledge of the Canadian healthcare landscape and the role specialty products play. She has particular expertise in rare diseases and market access.

Sandra has a Bachelor of Arts degree from McMaster, an MBA with a focus on international marketing, and is a CCRA (Certified Clinical Research Associate).